Rosemary Costello

1.1k total citations
12 papers, 864 citations indexed

About

Rosemary Costello is a scholar working on Surgery, Otorhinolaryngology and Oncology. According to data from OpenAlex, Rosemary Costello has authored 12 papers receiving a total of 864 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 8 papers in Otorhinolaryngology and 7 papers in Oncology. Recurrent topics in Rosemary Costello's work include Head and Neck Cancer Studies (8 papers), Head and Neck Surgical Oncology (6 papers) and Ear and Head Tumors (5 papers). Rosemary Costello is often cited by papers focused on Head and Neck Cancer Studies (8 papers), Head and Neck Surgical Oncology (6 papers) and Ear and Head Tumors (5 papers). Rosemary Costello collaborates with scholars based in United States. Rosemary Costello's co-authors include Marshall R. Posner, Robert I. Haddad, A. Dimitrios Colevas, Philip C. Amrein, Bonnie S. Glisson, Yi Li, Tamar Kotz, Roy B. Tishler, Linda Weeks and Dennis Cooper and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Clinical Cancer Research.

In The Last Decade

Rosemary Costello

12 papers receiving 847 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rosemary Costello United States 11 566 472 390 237 98 12 864
J.L.N. Roodenburg Netherlands 10 499 0.9× 530 1.1× 392 1.0× 178 0.8× 27 0.3× 16 970
Cesare Grandi Italy 9 476 0.8× 410 0.9× 426 1.1× 115 0.5× 8 0.1× 19 744
Akihiro Terada Japan 15 393 0.7× 330 0.7× 279 0.7× 83 0.4× 10 0.1× 37 591
Jay Boyle United States 10 322 0.6× 190 0.4× 387 1.0× 248 1.0× 29 0.3× 22 735
Kristine Bjørndal Denmark 16 805 1.4× 640 1.4× 221 0.6× 69 0.3× 8 0.1× 41 907
Martin Granados‐García Mexico 11 253 0.4× 126 0.3× 118 0.3× 135 0.6× 17 0.2× 44 550
Shira Abberbock United States 17 229 0.4× 286 0.6× 246 0.6× 250 1.1× 37 0.4× 20 654
Herman Lubsen Netherlands 15 812 1.4× 694 1.5× 373 1.0× 86 0.4× 3 0.0× 20 998
Samuel K.W. Chiu China 11 655 1.2× 435 0.9× 1.0k 2.6× 500 2.1× 20 0.2× 12 1.2k
Martin C. Jäckel Germany 13 336 0.6× 195 0.4× 391 1.0× 210 0.9× 18 0.2× 37 629

Countries citing papers authored by Rosemary Costello

Since Specialization
Citations

This map shows the geographic impact of Rosemary Costello's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosemary Costello with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosemary Costello more than expected).

Fields of papers citing papers by Rosemary Costello

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosemary Costello. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosemary Costello. The network helps show where Rosemary Costello may publish in the future.

Co-authorship network of co-authors of Rosemary Costello

This figure shows the co-authorship network connecting the top 25 collaborators of Rosemary Costello. A scholar is included among the top collaborators of Rosemary Costello based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosemary Costello. Rosemary Costello is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Haddad, Robert I. & Rosemary Costello. (2012). Medullary thyroid cancer: advances in treatment and management of common adverse events associated with therapy. Community Oncology. 9(6). 188–197. 1 indexed citations
2.
3.
Haddad, Robert I., Roy B. Tishler, Charles M. Norris, et al.. (2009). Phase I Study of C-TPF in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck. Journal of Clinical Oncology. 27(27). 4448–4453. 46 indexed citations
4.
Tishler, Roy B., Marshall R. Posner, Charles M. Norris, et al.. (2006). Concurrent weekly docetaxel and concomitant boost radiation therapy in the treatment of locally advanced squamous cell cancer of the head and neck. International Journal of Radiation Oncology*Biology*Physics. 65(4). 1036–1044. 26 indexed citations
5.
Glisson, Bonnie S., A. Dimitrios Colevas, Robert I. Haddad, et al.. (2004). HER2 Expression in Salivary Gland Carcinomas. Clinical Cancer Research. 10(3). 944–946. 158 indexed citations
6.
Kotz, Tamar, Rosemary Costello, Yi Li, & Marshall R. Posner. (2004). Swallowing dysfunction after chemoradiation for advanced squamous cell carcinoma of the head and neck. Head & Neck. 26(4). 365–372. 132 indexed citations
7.
Haddad, Robert I., Lisa J. Weinstein, Tad J. Wieczorek, et al.. (2004). A Phase II Clinical and Pharmacodynamic Study of E7070 in Patients with Metastatic, Recurrent, or Refractory Squamous Cell Carcinoma of the Head and Neck. Clinical Cancer Research. 10(14). 4680–4687. 49 indexed citations
8.
Haddad, Robert I., A. Dimitrios Colevas, Roy B. Tishler, et al.. (2003). Docetaxel, cisplatin, and 5‐fluorouracil‐based induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck. Cancer. 97(2). 412–418. 73 indexed citations
9.
Haddad, Robert I., Roy B. Tishler, Charles M. Norris, et al.. (2003). Docetaxel, Cisplatin, 5-Fluorouracil (TPF)-Based Induction Chemotherapy for Head and Neck Cancer and the Case for Sequential, Combined-Modality Treatment. The Oncologist. 8(1). 35–44. 45 indexed citations
10.
Haddad, Robert I., Lori J. Wirth, Rosemary Costello, Linda Weeks, & Marshall R. Posner. (2003). Phase II randomized study of concomitant chemoradiation using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with newly diagnosed locally advanced squamous cell carcinoma of the head and neck. Seminars in Oncology. 30(6 Suppl 18). 84–88. 14 indexed citations
11.
Haddad, Robert I., A. Dimitrios Colevas, Jeffrey F. Krane, et al.. (2003). Herceptin in patients with advanced or metastatic salivary gland carcinomas. A phase II study. Oral Oncology. 39(7). 724–727. 200 indexed citations
12.
Tishler, Roy B., Charles M. Norris, A. Dimitrios Colevas, et al.. (2002). A Phase I/II trial of concurrent docetaxel and radiation after induction chemotherapy in patients with poor prognosis squamous cell carcinoma of the head and neck. Cancer. 95(7). 1472–1481. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J.L.N. Roodenburg Breakdown of academic impact, for papers by Cesare Grandi Breakdown of academic impact, for papers by Akihiro Terada Breakdown of academic impact, for papers by Jay Boyle Breakdown of academic impact, for papers by Kristine Bjørndal Breakdown of academic impact, for papers by Martin Granados‐García Breakdown of academic impact, for papers by Shira Abberbock Breakdown of academic impact, for papers by Herman Lubsen Breakdown of academic impact, for papers by Samuel K.W. Chiu Breakdown of academic impact, for papers by Martin C. Jäckel
Rankless by CCL
2026